Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
about
The renin-angiotensin system and the heart: a historical reviewCellular localization and regional distribution of an angiotensin II-forming chymase in the heartReview article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseTranscriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitorPharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsCell coupling and impulse propagation in the failing heart.Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure.Macrophage roles following myocardial infarctionGene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes.Is inactivity the origin of essential hypertension: should we all be runners?The Renin-Angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle.Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboonIncreased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system.Association between the ACE insertion/deletion polymorphism and pterygium in Sardinian patients: a population based case-control studyAngiotensin-converting enzymes and drug discovery in cardiovascular diseases.Genetic polymorphisms and oxidative stress in heart failure.The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo.Exacerbation of ischemic dysfunction by angiotensin II in red cell-perfused rabbit hearts. Effects on coronary flow, contractility, and high-energy phosphate metabolism.The role of angiotensin-converting enzyme polymorphism in congestive heart failure.Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathwayEarly expression of all the components of the renin-angiotensin-system in human development.Cytokine mRNA expression in postischemic/reperfused myocardium.Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death.New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.Imaging the renin-angiotensin- aldosterone system in the heart.Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captoprilExtracellular matrix and fibroblast communication following myocardial infarction.Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.Left ventricular volumes, ejection fraction, and plasma proatrial natriuretic factor (1-98) after withdrawal of enalapril treatment initiated early after myocardial infarction. CONSENSUS II Multi-Echo Study Group.Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion.Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.Myocardial ischemia induces differential regulation of KATP channel gene expression in rat heartsDifferential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
P2860
Q24563079-B0A92701-8BAE-42F2-870C-9E00E527D7D1Q24599992-0DB8B568-0F8C-4A35-852A-C21B32CFF12DQ27009109-CE62FD10-9C21-4243-9BF9-07E5513BD247Q28077454-0CFD14CC-9F37-4796-9916-4B402C8A41CEQ28346501-65C450F5-7B6B-421A-A8BC-D7150AA2D684Q28554328-A635F98A-61E1-4DB8-BD22-45BBD8399F26Q33749051-1F7EDB6F-EE40-4416-97D3-4E17B11B0F9EQ33783409-FFD8A1D1-1A66-4CE4-9FE2-82E0A014387AQ33802153-978B6DD4-1B88-4EED-8CDB-A126723CEA9CQ33899056-CA6704CC-0792-4EAD-A648-BA63B52ED705Q33928314-4901F4C5-2F38-47F9-846C-60385E938AD5Q34079515-91F34969-163F-4D27-BCF3-5310333EC667Q34117578-D6098F13-E20B-4CD0-BC0A-AC4BB64FF138Q34206697-ED828275-C30A-44F9-95BB-08526A9ED527Q34235642-3486C11F-42D0-4C8A-92EB-5ADE1BD03131Q34291477-E70BBC3E-A84B-4C31-A99A-75DF29F14A54Q34397168-7ABCBF8F-215D-44F3-B547-36743D101EE9Q34423315-8986B2AB-2F5A-47D2-A5F7-8CBD5759BC50Q34667676-8E5686A1-52E7-44E8-BBC0-9CA13F02DE6FQ35027113-5BCDD86C-8754-4BD6-8BC0-93110FD18267Q35125969-41EA3795-2FCD-4B43-83E1-6A3B62520121Q35597637-43030C09-3EC2-4AE3-9C02-26A48BEA1C33Q35741732-B695AE59-C2C3-411B-A62E-F10FE8CF3E2DQ35763229-74EC42F9-2DC2-45A7-B88A-06CAA3DFC582Q35782663-03E8DDCF-56C1-4BA3-9531-5B499FBE71EAQ35796148-4C4BA5B3-220F-4BF9-8C4C-2F18EC53A0B3Q35810247-69AA7007-9684-48AC-9A66-A00E5E8450EDQ36191021-1FC85BA3-F54D-4869-A82D-5AB7DF576DA4Q36203157-F21B1B94-2ED0-4743-B0C9-E6B2CAE86617Q36411375-DE461E5E-F687-4787-9D97-32A93B418444Q36457257-4BCE0B32-CB98-472D-94CB-39252A669977Q36642656-9123033F-5365-4DF8-B790-946B90EB467DQ36820402-A4BC3AC2-0FC8-48E7-929B-F7E5D1605F9AQ37318301-A77EEB5B-6720-4B59-B909-5217B5675E70Q37862927-6683221A-7949-45CD-A821-0CB55626CB40Q39092008-3C8EAE00-CFC1-4181-B284-AFB74B97BA16Q39776974-F21B04A4-0CE2-41A2-9F5B-AE99823DA239Q39795853-9A88C950-44EA-48A1-8A91-32EFB5A3097AQ40134736-E9BA7734-494E-4C0C-B460-51F18B66DB92Q40341321-F7FEC27E-2D55-4B86-8366-414E89796B1B
P2860
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Tissue-specific activation of ...... in experimental heart failure.
@en
Tissue-specific activation of ...... in experimental heart failure.
@nl
type
label
Tissue-specific activation of ...... in experimental heart failure.
@en
Tissue-specific activation of ...... in experimental heart failure.
@nl
prefLabel
Tissue-specific activation of ...... in experimental heart failure.
@en
Tissue-specific activation of ...... in experimental heart failure.
@nl
P2093
P356
P1433
P1476
Tissue-specific activation of ...... in experimental heart failure.
@en
P2093
P304
P356
10.1161/01.RES.69.2.475
P577
1991-08-01T00:00:00Z